Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

LYSO-PROVE - Determine the Prognostic Value of Lyso-Gb1 for Monitoring the Progress of Gaucher Disease (LYSO-PROVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02416661
Recruitment Status : Recruiting
First Posted : April 15, 2015
Last Update Posted : April 30, 2019
Sponsor:
Information provided by (Responsible Party):
Centogene AG Rostock